We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Krystal Biotech Inc | NASDAQ:KRYS | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.97 | 1.41% | 213.66 | 201.32 | 279.92 | 219.34 | 210.80 | 213.24 | 234,535 | 23:41:13 |
From Jul 2021 to Jul 2024
Details for the event are as follows:
| Bank of America Merrill Lynch Global Healthcare Conference | ||
| Date: | Tuesday, May 10, 2022 | |
| Time: | 9:20am PDT | |
| Webcast Link: | https://bofa.veracast.com/webcasts/bofa/hc2022/id6InQpA.cfm | |
A webcast of the presentation will be available on the Investors section of the Company’s website for 90 days following the presentation.
About Krystal Biotech
Krystal Biotech, Inc. (NASDAQ: KRYS) is a pivotal-stage gene therapy company leveraging its proprietary, redosable gene therapy platform and in-house manufacturing capabilities to develop life-changing treatment options for patients with serious diseases, including rare diseases in skin, lung, and other areas. For more information, please visit http://www.krystalbio.com and follow @KrystalBiotech on LinkedIn and Twitter.
CONTACT:
Investors and Media:Meg DodgeKrystal Biotechmdodge@krystalbio.com
Source: Krystal Biotech, Inc.
1 Year Krystal Biotech Chart |
1 Month Krystal Biotech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
